Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
199.32
USD
-1.94 (-0.96%)
Streaming Delayed Price
Updated: 12:09 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
BRIEF-U.S. appeals court rejects Teva appeal in Lilly patent case over Alimta
January 12, 2017
Jan 12 (Reuters) - U.S. Appeals Court rules for Eli Lilly and against Teva Pharmaceutical in Alimta patent case -- court ruling
Tags
companyNews
From
Reuters: Company News
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
January 11, 2017
Tags
LLY
NVS
PFE
From
Motley Fool
What pharma investors ought to do after Donald Trump fires a salvo
January 11, 2017
Reduce exposure to those industries on fears of a drug-price crackdown, says Nigam Arora.
Tags
Pharmaceuticals
LABD
PPH
From
MarketWatch
BRIEF-Eli Lilly and Merck expand immuno-oncology collaboration
January 10, 2017
* Eli Lilly and co - financial details of collaboration were not disclosed.
Tags
companyNews
From
Reuters: Company News
Incyte's Prospects Get Even Brighter With Merck Announcement
January 09, 2017
Tags
MRK
LLY
INCY
From
Motley Fool
This Could Very Well Be the Greatest Drug Advancement in a Decade
January 09, 2017
Tags
LLY
BIIB
From
Motley Fool
Why Aratana Therapeutics Inc. Rocketed 42.7% Higher in 2016
January 09, 2017
Tags
LLY
PETX
From
Motley Fool
Five unpopular, but prudent, things for investors to do near Dow 20,000
January 09, 2017
It’s time to sell over-owned stocks and trim some others, says Nigam Arora.
Tags
JNJ
TTEK
Manufacturing
From
MarketWatch
The MedTech Group: 2017 Top Picks And Catalysts
January 06, 2017
Over the past year, the gap between MedTech stocks and the S&P index has narrowed significantly, and these are currently trading ...
Tags
BSX
Eurozone
PODD
From
Benzinga
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
January 06, 2017
Tags
MRK
LLY
BMY
From
Motley Fool
BRIEF-Lilly to adjust organization and leadership structure to better align with growth opportunities
January 04, 2017
* Lilly to adjust organization and leadership structure to better align with growth opportunities
Tags
companyNews
From
Reuters: Company News
BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines
January 04, 2017
* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin...
Tags
companyNews
From
Reuters: Company News
Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court
January 04, 2017
Drugmaker Eli Lilly will likely add a rheumatoid arthritis drug to its FDA-approved repertoire this month, Credit Suisse says.
Tags
Technology
From
Investor's Business Daily
My Worst Predictions for Biotech in 2016
January 03, 2017
Tags
KITE
BIIB
EDIT
From
Motley Fool
Two Key FDA Decisions To Watch Out For In January 2017
January 02, 2017
Several drug companies could see regulatory milestones passed in January 2017. Here's a look at a couple of important regulatory events scheduled for this month.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive
January 02, 2017
Amgen expects to compete robustly in the anti-CGRP migraine market vs. Alder BioPharma, Teva Pharmaceutical and Eli Lilly.
Tags
Technology
From
Investor's Business Daily
In the age of Uber and Lyft, it’s still hard for some Americans to get to the doctor
December 29, 2016
When a researcher first started looking at high diabetes rates among Bangladeshi Americans, transportation was the heart of the problem.
Tags
SPX
Retail
Personal Finance
From
MarketWatch
Johnson & Johnson's 4 Biggest Catalysts in 2017
December 29, 2016
Tags
ABBV
JNJ
LLY
From
Motley Fool
UPDATE 1-U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
December 28, 2016
WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would...
Tags
companyNews
From
Reuters: Company News
A Preview Of January PDUFA Dates
December 28, 2016
Biopharma companies did not have much to write home about in the year 2016, as negative news flow on price gouging hit many stocks in ...
Tags
XBI
News
General
From
Benzinga
VTV, USB, LLY, LMT: ETF Inflow Alert
December 28, 2016
Symbols mentioned in this story: VTV, USB, LLY, LMT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
December 27, 2016
Biogen Inc (NASDAQ: BIIB) said its newly approved Spinraza (nusinersen) would be available in just one week time. Spinraza is approved ...
Tags
General
News
Previews
From
Benzinga
Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
December 27, 2016
PARIS/NEW YORK, Dec 27 (Reuters) - France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many...
Tags
companyNews
From
Reuters: Company News
Migraine drugs may repeat rheumatoid arthritis success
December 23, 2016
Dec 23 (Reuters) - Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder.
Tags
companyNews
From
Reuters: Company News
J&J Back In Talks With Actelion, Teva Settles Corruption Probe
December 23, 2016
Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal.
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Gilead Is A Hail Mary: 3 Better Stocks To Consider
December 23, 2016
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead, which is down 25.2%.
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
6 Worst Biotech Stocks Of 2016
December 23, 2016
The biotech space is inherently fraught with risks, risks of failures in clinical trials, regulatory logjams, political policies ...
Tags
OPHT
NVAX
LLY
From
Benzinga
The Most Likely Incyte Acquisition Deal for 2017?
December 23, 2016
Tags
GILD
LLY
INCY
From
Motley Fool
Trump health secretary nominee has bought and sold $300,000 in health care stocks while in office
December 22, 2016
While sponsoring many health-related bills in the House.
Tags
Construction and Materials
Retail
LLY
From
MarketWatch
Two Lessons From My Biogen Trade
December 22, 2016
One can be wrong and make money and be right and lose money. Here is how I made money on Biogen Inc.
Tags
Options
Pharma/Biotech
From
Blogs - TalkMarkets
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.